Fitness advantage of Bacteroides thetaiotaomicron capsular polysaccharide in the mouse gut depends on the resident microbiota

  1. Daniel Hoces
  2. Giorgia Greter
  3. Markus Arnoldini
  4. Melanie L Stäubli
  5. Claudia Moresi
  6. Anna Sintsova
  7. Sara Berent
  8. Isabel Kolinko
  9. Florence Bansept
  10. Aurore Woller
  11. Janine Häfliger
  12. Eric Martens
  13. Wolf-Dietrich Hardt
  14. Shinichi Sunagawa
  15. Claude Loverdo
  16. Emma Slack  Is a corresponding author
  1. ETH Zurich, Switzerland
  2. Max Planck Institute for Evolutionary Biology, Germany
  3. Weizmann Institute of Science, Israel
  4. University Hospital of Zurich, Switzerland
  5. University of Michigan-Ann Arbor, United States
  6. UPMC, CNRS, France

Abstract

Many microbiota-based therapeutics rely on our ability to introduce a microbe of choice into an already-colonized intestine. In this study, we used genetically barcoded Bacteroides thetaiotaomicron (B. theta) strains to quantify population bottlenecks experienced by a B. theta population during colonization of the mouse gut. As expected, this reveals an inverse relationship between microbiota complexity and the probability that an individual wildtype B. theta clone will colonize the gut. The polysaccharide capsule of B. theta is important for resistance against attacks from other bacteria, phage, and the host immune system, and correspondingly acapsular B. theta loses in competitive colonization against the wildtype strain. Surprisingly, the acapsular strain did not show a colonization defect in mice with a low-complexity microbiota, as we found that acapsular strains have an indistinguishable colonization probability to the wildtype strain on single-strain colonization. This discrepancy could be resolved by tracking in vivo growth dynamics of both strains: acapsular B .theta shows a longer lag-phase in the gut lumen as well as a slightly slower net growth rate. Therefore, as long as there is no niche competitor for the acapsular strain, this has only a small influence on colonization probability. However, the presence of a strong niche competitor (i.e., wildtype B. theta, SPF microbiota) rapidly excludes the acapsular strain during competitive colonization. Correspondingly, the acapsular strain shows a similarly low colonization probability in the context of a co-colonization with the wildtype strain or a complete microbiota. In summary, neutral tagging and detailed analysis of bacterial growth kinetics can therefore quantify the mechanisms of colonization resistance in differently-colonized animals.

Data availability

Relevant numerical source data for Figures and Supplementary is available in Source Data 1. Raw sequencing data accessed on ENA (https://www.ebi.ac.uk/ena/browser/home) under Project ID PRJEB57876 and PRJEB53981. Raw data and code used for generating all figures in this publication are made available in a curated data archive at ETH Zurich (https://www.research-collection.ethz.ch/) under the DOI 10.3929/ethz-b-000557179.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Daniel Hoces

    Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  2. Giorgia Greter

    Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  3. Markus Arnoldini

    Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Melanie L Stäubli

    Department of Biology, ETH Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Claudia Moresi

    Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  6. Anna Sintsova

    Department of Biology, ETH Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  7. Sara Berent

    Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  8. Isabel Kolinko

    Department of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  9. Florence Bansept

    Department for Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Plön, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0562-9222
  10. Aurore Woller

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  11. Janine Häfliger

    Klinik für Gastroenterologie und Hepatologie, University Hospital of Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  12. Eric Martens

    Department of Microbiology and Immunology, University of Michigan-Ann Arbor, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Wolf-Dietrich Hardt

    Department of Biology, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9892-6420
  14. Shinichi Sunagawa

    Department of Biology, ETH Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3065-0314
  15. Claude Loverdo

    UPMC, CNRS, Paris Cedex 05, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0888-1717
  16. Emma Slack

    Department of Health Sciences and Techn, ETH Zurich, Zurich, Switzerland
    For correspondence
    emma.slack@hest.ethz.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2473-1145

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (NCCR Microbiome)

  • Wolf-Dietrich Hardt
  • Shinichi Sunagawa
  • Emma Slack

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (40B2-0_180953)

  • Emma Slack

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_185128)

  • Emma Slack

Gebert Rüf Stiftung (GR073_17)

  • Claude Loverdo
  • Emma Slack

Botnar Research Centre for Child Health, University of Basel (BRCCH_MIP)

  • Shinichi Sunagawa
  • Emma Slack

Agence Nationale de la Recherche (ANR-21-CE45-0015)

  • Claude Loverdo

Agence Nationale de la Recherche (ANR-20-CE30-0001)

  • Claude Loverdo

Centre National de la Recherche Scientifique (MITI CNRS AAP adaptation du vivant à son environnement)

  • Claude Loverdo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Matthew K Waldor, Brigham and Women's Hospital, United States

Ethics

Animal experimentation: All animal experiments were performed with approval from the Zürich Cantonal Authority under license number ZH120/19.

Version history

  1. Preprint posted: June 19, 2022 (view preprint)
  2. Received: June 20, 2022
  3. Accepted: February 8, 2023
  4. Accepted Manuscript published: February 9, 2023 (version 1)
  5. Version of Record published: March 14, 2023 (version 2)

Copyright

© 2023, Hoces et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,736
    views
  • 290
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Daniel Hoces
  2. Giorgia Greter
  3. Markus Arnoldini
  4. Melanie L Stäubli
  5. Claudia Moresi
  6. Anna Sintsova
  7. Sara Berent
  8. Isabel Kolinko
  9. Florence Bansept
  10. Aurore Woller
  11. Janine Häfliger
  12. Eric Martens
  13. Wolf-Dietrich Hardt
  14. Shinichi Sunagawa
  15. Claude Loverdo
  16. Emma Slack
(2023)
Fitness advantage of Bacteroides thetaiotaomicron capsular polysaccharide in the mouse gut depends on the resident microbiota
eLife 12:e81212.
https://doi.org/10.7554/eLife.81212

Share this article

https://doi.org/10.7554/eLife.81212

Further reading

    1. Microbiology and Infectious Disease
    2. Structural Biology and Molecular Biophysics
    Alexander D Cook, Mark Carrington, Matthew K Higgins
    Research Article

    African trypanosomes replicate within infected mammals where they are exposed to the complement system. This system centres around complement C3, which is present in a soluble form in serum but becomes covalently deposited onto the surfaces of pathogens after proteolytic cleavage to C3b. Membrane-associated C3b triggers different complement-mediated effectors which promote pathogen clearance. To counter complement-mediated clearance, African trypanosomes have a cell surface receptor, ISG65, which binds to C3b and which decreases the rate of trypanosome clearance in an infection model. However, the mechanism by which ISG65 reduces C3b function has not been determined. We reveal through cryogenic electron microscopy that ISG65 has two distinct binding sites for C3b, only one of which is available in C3 and C3d. We show that ISG65 does not block the formation of C3b or the function of the C3 convertase which catalyses the surface deposition of C3b. However, we show that ISG65 forms a specific conjugate with C3b, perhaps acting as a decoy. ISG65 also occludes the binding sites for complement receptors 2 and 3, which may disrupt recruitment of immune cells, including B cells, phagocytes, and granulocytes. This suggests that ISG65 protects trypanosomes by combining multiple approaches to dampen the complement cascade.

    1. Microbiology and Infectious Disease
    Michael D Sacco, Lauren R Hammond ... Yu Chen
    Research Article

    In the Firmicutes phylum, GpsB is a membrane associated protein that coordinates peptidoglycan synthesis with cell growth and division. Although GpsB has been studied in several bacteria, the structure, function, and interactome of Staphylococcus aureus GpsB is largely uncharacterized. To address this knowledge gap, we solved the crystal structure of the N-terminal domain of S. aureus GpsB, which adopts an atypical, asymmetric dimer, and demonstrates major conformational flexibility that can be mapped to a hinge region formed by a three-residue insertion exclusive to Staphylococci. When this three-residue insertion is excised, its thermal stability increases, and the mutant no longer produces a previously reported lethal phenotype when overexpressed in Bacillus subtilis. In S. aureus, we show that these hinge mutants are less functional and speculate that the conformational flexibility imparted by the hinge region may serve as a dynamic switch to finetune the function of the GpsB complex and/or to promote interaction with its various partners. Furthermore, we provide the first biochemical, biophysical, and crystallographic evidence that the N-terminal domain of GpsB binds not only PBP4, but also FtsZ, through a conserved recognition motif located on their C-termini, thus coupling peptidoglycan synthesis to cell division. Taken together, the unique structure of S. aureus GpsB and its direct interaction with FtsZ/PBP4 provide deeper insight into the central role of GpsB in S. aureus cell division.